ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.737,36
-0,64%
S&P 500
4.967,23
-0,88%
Dow Jones
37.986,40
0,56%
Euro vs US Dollar
1,06705
0,00%
Bitcoin
64.800,00
1,53%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) News

ABT Abbott Laboratories

107,30
2,03 (1,93%)
20 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Abbott Laboratories ABT NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
2,03 1,93% 107,30 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
105,98 105,38 107,77 107,28 105,27
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.4.202417:37IHMARKETNEWSAbbott Laboratories Reports Strong Q1 Sales Growth Amid..
17.4.202413:30PRNUSAbbott Reports First-Quarter 2024 Results and Raises..
17.4.202412:59IHMARKETNEWSUS Index Futures See Gains, Oil Prices Dip
03.4.202413:12IHMARKETNEWSCal-Maine Surges on Strong Quarterly Performance, Taiwan..
02.4.202415:00PRNUSAbbott Receives FDA Approval for TriClip™, First-of-Its-Kind..
01.4.202415:00PRNUSAbbott Receives FDA Clearance for Whole Blood Rapid Test to..
27.3.202421:30PRNUSAbbott Hosts Conference Call for First-Quarter Earnings
19.3.202413:00PRNCAUne première au Canada -- Abbott fait progresser le..
06.3.202415:00PRNUSReal-World Data Show Abbott's FreeStyle Libre® Systems and..
05.3.202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:53EDGAR2Form 144 - Report of proposed sale of securities
01.3.202423:45EDGAR2Form 144 - Report of proposed sale of securities
01.3.202423:39EDGAR2Form 144 - Report of proposed sale of securities
01.3.202423:32EDGAR2Form 144 - Report of proposed sale of securities
01.3.202423:25EDGAR2Form 144 - Report of proposed sale of securities
01.3.202423:22EDGAR2Form 144 - Report of proposed sale of securities
28.2.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:02EDGAR2Form 144 - Report of proposed sale of securities
16.2.202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16.2.202416:19PRNUSAbbott Declares 401st Consecutive Quarterly Dividend
14.2.202400:47PRNUSFDA Advisory Committee Votes in Favor of Abbott's..
13.2.202422:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.2.202411:31IHMARKETNEWSSantander’s Stock Declines Amid Sanctions Evasion Scandal,..
01.2.202415:00PRNUSNew Study Shows Mixed Reality Technology for Blood Donation..
31.1.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202415:00PRNUSAbbott Launches New PROTALITY™ Brand to Support Adults on..
29.1.202422:10EDGAR2Form 8-K - Current report
29.1.202422:04EDGAR2Form 144 - Report of proposed sale of securities
26.1.202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25.1.202415:00PRNUSAbbott Launches World's Smallest Rechargeable System With..
25.1.202412:25IHMARKETNEWSWall Street Highlights: Nokia’s Margins Surprise, FAA Halts..

Kürzlich von Ihnen besucht

NYSE
ABT
Abbott Laboratories
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten